Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the HMG-CoA Reductase Inhibitor Atorvastatin Calcium, Lipitor, in the Treatment of Alzheimer's Disease

NCT00024531 is registered in ClinicalTrials.gov with Institute for the Study of Aging (ISOA) as lead sponsor.

NCT NCT00024531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00024531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the HMG-CoA Reductase Inhibitor Atorvastatin Calcium, Lipitor, in the Treatment of Alzheimer's Disease
Lead sponsor
Institute for the Study of Aging (ISOA)
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2000
Completion date
August 31, 2004
Enrollment
98
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease